SCHEMBL9328357

SCHEMBL9328357

CNCCCC(N)(CCCCCCCN)CCCNC

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 2/20 0.36
DNM1 Q05193 6/20 0.35
CA12 O43570 2/20 0.35
CA1 P00915 2/20 0.35
CA2 P00918 2/20 0.35
CA3 P07451 2/20 0.35
CA4 P22748 2/20 0.35
CA6 P23280 2/20 0.35
CA5A P35218 2/20 0.35
CA7 P43166 2/20 0.35
CA9 Q16790 2/20 0.35
CA14 Q9ULX7 2/20 0.35
CA5B Q9Y2D0 2/20 0.35
TSHR P16473 2/20 0.35
LMNA P02545 1/20 0.35
BLM P54132 1/20 0.35
PAOX Q6QHF9 2/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
ALDH1A1 P00352 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19118974 0.89 EPHX1 (0.35) EPHX1CA12CA6CA7CA9
SCHEMBL817593 0.81 DNM1 (0.47) EPHX1DNM1CA12CA1CA2
SCHEMBL20425510 0.81 DNM1 (0.53) EPHX1DNM1CA12CA1CA2
SCHEMBL9185412 0.79 CYP2C19 (0.41) EPHX1DNM1CA12CA1CA2
SCHEMBL9067349 0.79 CYP2C19 (0.41) EPHX1DNM1CA12CA1CA2
SCHEMBL9723372 0.78 EPHX1 (0.65) EPHX1TSHRALDH1A1FDPS
SCHEMBL34358 0.78
SCHEMBL487567 0.78
SCHEMBL8502653 0.78 EPHX1 (0.55) EPHX1DNM1CA12CA1CA2
SCHEMBL1408879 0.78 EPHX1 (0.55) EPHX1DNM1CA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0311068-A2 Polyamine derivatives as antineoplastic agents MERRELL DOW PHARMACEUTICALS INC. (US) 1989-04-12 EP claimed
EP-0311068-B1 Polyamine derivatives as antineoplastic agents MERRELL DOW PHARMA (US) 1994-03-30 EP disclosed
EP-0311068-A2 Polyamine derivatives as antineoplastic agents MERRELL DOW PHARMACEUTICALS INC. (US) 1989-04-12 EP disclosed